Cargando…

Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1

Cancer stem cells (CSCs) represent rare tumor cell populations capable of self-renewal, differentiation, and tumor initiation and are highly resistant to chemotherapy and radiotherapy. Thus, therapeutic approaches that can effectively target CSCs and tumor cells could be the key to efficient tumor t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hii, Ling-Wei, Chung, Felicia Fei-Lei, Mai, Chun Wai, Yee, Zong Yang, Chan, Hong Hao, Raja, Vijay Joseph, Dephoure, Noah Elias, Pyne, Nigel J., Pyne, Susan, Leong, Chee-Onn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226795/ https://www.ncbi.nlm.nih.gov/pubmed/32260399 http://dx.doi.org/10.3390/cells9040886

Ejemplares similares

Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Hii, Ling-Wei, et al.
Publicado: (2021)

Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
por: Pyne, Susan, et al.
Publicado: (2012)

Does the Sphingosine 1-Phosphate Receptor-1 Provide a Better or Worse Prognostic Outcome for Breast Cancer Patients?
por: Pyne, Nigel J., et al.
Publicado: (2018)

Sphingosine 1-Phosphate Receptor 1 Signaling in Mammalian Cells
por: Pyne, Nigel J., et al.
Publicado: (2017)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor negative breast cancer
por: Ohotski, J, et al.
Publicado: (2012)

Selectivity and Specificity of Sphingosine 1-Phosphate Receptor Ligands: “Off-Targets” or Complex Pharmacology?
por: Pyne, Nigel J., et al.
Publicado: (2011)

Sphingosine kinase 2 and multiple myeloma
por: Pyne, Nigel J., et al.
Publicado: (2017)

A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells
por: Brown, Ryan D.R., et al.
Publicado: (2021)

Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells
por: McNaughton, Melissa, et al.
Publicado: (2016)

The Roles of Sphingosine Kinase 1 and 2 in Regulating the Metabolome and Survival of Prostate Cancer Cells
por: Tonelli, Francesca, et al.
Publicado: (2013)

FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells
por: Tonelli, Francesca, et al.
Publicado: (2010)

The sphingosine 1-phosphate receptor 2 is shed in exosomes from breast cancer cells and is N-terminally processed to a short constitutively active form that promotes extracellular signal regulated kinase activation and DNA synthesis in fibroblasts
por: El Buri, Ashref, et al.
Publicado: (2018)

Structure–Activity Relationships and Molecular Modeling of Sphingosine Kinase Inhibitors
por: Baek, Dong Jae, et al.
Publicado: (2013)

Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse
por: Greig, Fiona H., et al.
Publicado: (2019)

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?
por: Looi, Chin-King, et al.
Publicado: (2020)

Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase
por: Berdyshev, Evgeny V., et al.
Publicado: (2011)

Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension
por: MacRitchie, Neil, et al.
Publicado: (2016)

Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer
por: Wen, Wei Xiong, et al.
Publicado: (2019)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
por: Looi, Chin King, et al.
Publicado: (2021)

Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
por: Tsuchida, Junko, et al.
Publicado: (2017)

Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells
por: Nalairndran, Geetha, et al.
Publicado: (2021)

Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
por: Sim, Wynne, et al.
Publicado: (2022)

Phosphoinositide‐dependent Kinase‐1 (PDPK1) regulates serum/glucocorticoid‐regulated Kinase 3 (SGK3) for prostate cancer cell survival
por: Nalairndran, Geetha, et al.
Publicado: (2020)

Regulation of cell survival by sphingosine-1-phosphate receptor S1P(1) via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1
por: Rutherford, C, et al.
Publicado: (2013)

Divergence of Intracellular Trafficking of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 3 in MCF-7 Breast Cancer Cells and MCF-7-Derived Stem Cell-Enriched Mammospheres
por: Sukocheva, Olga A., et al.
Publicado: (2021)

Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer
por: Looi, Chin-King, et al.
Publicado: (2022)

Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
por: Gan, Li-Lian, et al.
Publicado: (2020)

A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes
por: Shin, Sun-Hye, et al.
Publicado: (2020)

The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management
por: Patel, Dutt S, et al.
Publicado: (2021)

Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
por: Ng, Mei Li, et al.
Publicado: (2018)

Survival benefit of sphingosin‐1‐phosphate and receptors expressions in breast cancer patients
por: Lei, Fu‐Ju, et al.
Publicado: (2018)

Overexpression of sphingosine kinase 1 is predictive of poor prognosis in human breast cancer
por: Zhu, Ya-Jing, et al.
Publicado: (2017)

Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
por: Khan, Faez Iqbal, et al.
Publicado: (2019)

Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis
por: Wang, Shushu, et al.
Publicado: (2018)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics
por: Evangelisti, Cecilia, et al.
Publicado: (2014)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

Macrophage-mediated breast cancer cell chemotaxis: the role of sphingosine kinase-1 activation
por: Nunes, J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_51hva0sbakg3o4ub3vomrmdp3o